Consolidated statement of comprehensive income
January 1 – December 31
|
millions of CHF |
|
|
2024 |
|
2023 |
|
|
|
Net income |
|
|
|
–6.4 |
|
0.7 |
|
|
|
|
|
|
|
|
|
|
|
Items that are or may be reclassified subsequently to the income statement |
|
|
|
|
|
|
|
|
Cash flow hedges, net of tax |
|
|
–5.0 |
|
–1.6 |
|
|
|
Currency translation differences |
|
|
|
6.7 |
|
–25.0 |
|
|
Total items that are or may be reclassified subsequently to the income statement |
|
|
|
1.6 |
|
–26.6 |
|
|
|
|
|
|
|
|
|
|
|
Items that will not be reclassified to the income statement |
|
|
|
|
|
|
|
|
Remeasurements of defined benefit plans, net of tax |
|
|
–1.3 |
|
19.5 |
|
|
|
Total items that will not be reclassified to the income statement |
|
|
|
–1.3 |
|
19.5 |
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income |
|
|
|
0.3 |
|
–7.1 |
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income for the period |
|
|
|
–6.0 |
|
–6.4 |
|
|
- thereof attributable to shareholders of medmix Ltd |
|
|
|
–7.4 |
|
–6.4 |
|
|
- thereof attributable to non-controlling interests |
|
|
|
1.4 |
|
–0.0 |
|